Laurion Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Laurion Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-16,123	Closed	-$34.3K	–	676
2023 Q1	$34.3K	Buy	+16,123	New	+$39.8K	﹤0.01%	417
2022 Q2	–	Sell	-252,338	Closed	-$1.92M	–	647
2022 Q1	$1.92M	Buy	+252,338	New	+$1.95M	0.02%	214
2021 Q2	–	Sell	-110,141	Closed	-$2.01M	–	888
2021 Q1	$2.01M	Sell	110,141 -452,839	-80%	-$6.14M	0.01%	425
2020 Q4	$4.24M	Buy	+562,980	New	+$2.67M	0.03%	265
2020 Q1	–	Sell	-25,000	Closed	-$120K	–	996
2019 Q4	$120K	Buy	+25,000	New	+$158K	﹤0.01%	833

Other funds holding ORGO

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Laurion Capital Management's ORGO Position: Q2 2023 in Review

Laurion Capital Management sold out of Organogenesis Holdings (ORGO) in Q2 2023, closing a stake of 16,123 shares — an estimated $34.3K sold.

Laurion Capital Management first reported a position in ORGO in Q4 2019 and held it in 5 quarters. The position peaked at $4.24M in Q4 2020. 113 funds tracked by Wall St. Rank hold ORGO as of Q2 2023.

Laurion Capital Management reported no remaining Organogenesis Holdings position as of Q2 2023 after selling out during the quarter.
Laurion Capital Management sold 16,123 Organogenesis Holdings shares in Q2 2023, an estimated $34.3K.
Laurion Capital Management first reported a position in Organogenesis Holdings in Q4 2019 and held it in 5 quarters.
Laurion Capital Management's Organogenesis Holdings position peaked at $4.24M in Q4 2020.
113 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2023.

Based on Laurion Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.